The National Times - Asian, European markets rally ahead of US jobs data

Asian, European markets rally ahead of US jobs data


Asian, European markets rally ahead of US jobs data

Asian and European markets advanced on Friday, in line with a global equity rally ahead of a US jobs report that will give insight about the Federal Reserve's next move on interest rates.

Change text size:

A frenzied selloff of Chinese stocks meanwhile slowed over reports of a regulatory clampdown.

The global bond market also eased after yields had jumped this week on concerns over mounting government debt.

London, Paris and Frankfurt were having a fair time of it, trading up at the open on Friday.

Across the pond, investors will be looking to US government jobs data due on Friday to cement rate-cut bets.

"All eyes will be on Friday's nonfarm payrolls report with bad news likely to be interpreted as good news as it will raise the market probability that the Fed cuts rates," said Victoria Scholar, head of investment at Interactive Investor.

Weekly data released on Thursday showed more first-time claims for unemployment benefits in the United States than analysts had expected, while figures from payroll firm ADP showed slowing private sector hiring in August.

"Investors now look for final confirmation that the weakening trend is entrenched and justifies a Fed cut –- or two," said Ipek Ozkardeskaya of Swissquote bank.

In Asia, an August rally in Chinese stocks, fuelled by surging shares in semiconductor firms, ground to a halt this week, with Cambricon Technologies crashing 14 percent on Thursday, as investors weighed potential regulations.

China's blue-chip CSI 300 benchmark was recovering on Friday after falling 2.1 percent the previous day -- the largest drop since early April, when US President Donald Trump's tariff threats caused the index to drop more than seven percent in one day.

Tokyo and Hong Kong were both up on Friday and Shanghai's benchmark index, which was tracking down in early trading, had clawed back up.

Analysts said earlier falls had followed a Bloomberg report that China's financial regulators might implement measures to cool the pace of the selloff in stocks.

"The selloff is more than a blip; it's the first crack in the facade of a $1.2 trillion melt-up that had traders whispering about deja-vu and a speculative frenzy reminiscent of the 2015 'crazy bull'," said Stephen Innes of SPI Asset Management.

Japanese long-term government debt yields also eased on Friday, while the Nikkei failed to extend early-session gains.

Gold remained a refuge for investors, who have been turning away from long-term bonds once considered safe assets.

Bullion consolidated near its all-time high, while oil prices extended losses on Friday in anticipation of excess supply in the coming months, as OPEC+ nations are expected to further unwind production cuts.

"Geopolitical risks... remain elevated, with mounting fears of further Russian attacks on Ukraine. That keeps downside potential in oil limited, likely into the $60–62 range," Swissquote's Ozkardeskaya said.

Oil has tumbled 12 percent this year as global producers outside OPEC+ ramp up and tariffs curb demand.

- Key figures at around 0715 GMT -

Tokyo - Nikkei 225: UP 1.0 percent at 43,018.75

Hong Kong - Hang Seng Index: UP 1.54 percent at 25,445.60

Shanghai - Composite: UP 1.24 percent at 3,812.51

London - FTSE 100: UP 0.3 percent at 9,240.84

Paris - CAC 40: UP 0.3 percent at 7,723.97

Frankfurt - DAX: UP 0.7 percent at 23843.24

Euro/dollar: UP at $1.1673 from $1.1649 on Thursday

Pound/dollar: UP at $1.3455 from $1.3437

Dollar/yen: DOWN at 148.24 yen from 148.45 yen

Euro/pound: UP at 86.75 pence from 86.72 pence

West Texas Intermediate: DOWN 0.5 percent at $63.15 per barrel

Brent North Sea Crude: DOWN 0.4 percent at $66.72 per barrel

New York - Dow: UP 0.8 percent at 45,621.29 (close)

F.Hughes--TNT

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

Change text size: